323 related articles for article (PubMed ID: 28110422)
1. Interventions for Neurocognitive Dysfunction.
Ellero J; Lubomski M; Brew B
Curr HIV/AIDS Rep; 2017 Feb; 14(1):8-16. PubMed ID: 28110422
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic approaches to HIV-associated neurocognitive disorders.
Avedissian SN; Dyavar SR; Fox HS; Fletcher CV
Curr Opin Pharmacol; 2020 Oct; 54():102-108. PubMed ID: 33049585
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy.
Anderson AM; Muñoz-Moreno JA; McClernon DR; Ellis RJ; Cookson D; Clifford DB; Collier AC; Gelman BB; Marra CM; McArthur JC; McCutchan JA; Morgello S; Sacktor N; Simpson DM; Franklin DR; Heaton RK; Grant I; Letendre SL;
J Infect Dis; 2017 Jan; 215(1):105-113. PubMed ID: 27789723
[TBL] [Abstract][Full Text] [Related]
4. HIV associated neurocognitive disorders in the modern antiviral treatment era: prevalence, characteristics, biomarkers, and effects of treatment.
Chan P; Brew BJ
Curr HIV/AIDS Rep; 2014 Sep; 11(3):317-24. PubMed ID: 24966139
[TBL] [Abstract][Full Text] [Related]
5. Aging, comorbidities, and the importance of finding biomarkers for HIV-associated neurocognitive disorders.
Rosenthal J; Tyor W
J Neurovirol; 2019 Oct; 25(5):673-685. PubMed ID: 30868422
[TBL] [Abstract][Full Text] [Related]
6. HIV-associated neurocognitive disorders: perspective on management strategies.
Nabha L; Duong L; Timpone J
Drugs; 2013 Jun; 73(9):893-905. PubMed ID: 23733447
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic biomarkers for HAND.
McLaurin KA; Booze RM; Mactutus CF
J Neurovirol; 2019 Oct; 25(5):686-701. PubMed ID: 30607890
[TBL] [Abstract][Full Text] [Related]
8. HIV-Associated Neurocognitive Disorders--An issue of Growing Importance.
Chan LG; Wong CS
Ann Acad Med Singap; 2013 Oct; 42(10):527-34. PubMed ID: 24254240
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 and Compromised Adult Neurogenesis: Emerging Evidence for a New Paradigm of HAND Persistence.
Putatunda R; Ho WZ; Hu W
AIDS Rev; 2019; 21(1):11-22. PubMed ID: 30899112
[TBL] [Abstract][Full Text] [Related]
10. CNS Neurotoxicity of Antiretrovirals.
Lanman T; Letendre S; Ma Q; Bang A; Ellis R
J Neuroimmune Pharmacol; 2021 Mar; 16(1):130-143. PubMed ID: 31823251
[TBL] [Abstract][Full Text] [Related]
11. HIV, antiretroviral therapies, and the brain.
Liner KJ; Ro MJ; Robertson KR
Curr HIV/AIDS Rep; 2010 May; 7(2):85-91. PubMed ID: 20425562
[TBL] [Abstract][Full Text] [Related]
12. CROI 2014: Neurologic complications of HIV infection.
Spudich SS
Top Antivir Med; 2014 May; 22(2):594-601. PubMed ID: 24901885
[TBL] [Abstract][Full Text] [Related]
13. HIV-related neurocognitive disorders: Diagnosis, Treatment, and Mental Health Implications: A Review.
Elendu C; Aguocha CM; Okeke CV; Okoro CB; Peterson JC
Medicine (Baltimore); 2023 Oct; 102(43):e35652. PubMed ID: 37904369
[TBL] [Abstract][Full Text] [Related]
14. Developments in Neuroprotection for HIV-Associated Neurocognitive Disorders (HAND).
Kolson DL
Curr HIV/AIDS Rep; 2022 Oct; 19(5):344-357. PubMed ID: 35867211
[TBL] [Abstract][Full Text] [Related]
15. Current understanding of HIV-associated neurocognitive disorders pathogenesis.
Gannon P; Khan MZ; Kolson DL
Curr Opin Neurol; 2011 Jun; 24(3):275-83. PubMed ID: 21467932
[TBL] [Abstract][Full Text] [Related]
16. HIV and neurocognitive dysfunction.
Spudich S
Curr HIV/AIDS Rep; 2013 Sep; 10(3):235-43. PubMed ID: 23860944
[TBL] [Abstract][Full Text] [Related]
17. HIV-associated neurocognitive disorder.
Clifford DB
Curr Opin Infect Dis; 2017 Feb; 30(1):117-122. PubMed ID: 27798498
[TBL] [Abstract][Full Text] [Related]
18. Interrogating the impact of combination antiretroviral therapies on HIV-associated neurocognitive disorders.
Sharma I
HIV Med; 2021 Oct; 22(9):783-790. PubMed ID: 34291558
[TBL] [Abstract][Full Text] [Related]
19. Reversible large-scale network disruption correlates with neurocognitive improvement in HIV-associated minor neurocognitive disorder with combined anti-retroviral therapy intensification: a prospective longitudinal resting-state functional magnetic resonance imaging study.
Chaganti J; Gates TM; Brew BJ
Neurol Sci; 2023 Sep; 44(9):3261-3269. PubMed ID: 37052787
[TBL] [Abstract][Full Text] [Related]
20. Anemia and Red Blood Cell Indices Predict HIV-Associated Neurocognitive Impairment in the Highly Active Antiretroviral Therapy Era.
Kallianpur AR; Wang Q; Jia P; Hulgan T; Zhao Z; Letendre SL; Ellis RJ; Heaton RK; Franklin DR; Barnholtz-Sloan J; Collier AC; Marra CM; Clifford DB; Gelman BB; McArthur JC; Morgello S; Simpson DM; McCutchan JA; Grant I;
J Infect Dis; 2016 Apr; 213(7):1065-73. PubMed ID: 26690344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
